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Annexin A1 Deficiency does  
not Affect Myofiber Repair but  
Delays Regeneration of Injured 
Muscles
Evgenia Leikina1,*, Aurelia Defour2,*, Kamran Melikov1, Jack H. Van der Meulen2, 
Kanneboyina Nagaraju2,4, Shivaprasad Bhuvanendran2, Claudia Gebert3, Karl Pfeifer3, 
Leonid V. Chernomordik1 & Jyoti K. Jaiswal2,4
Repair and regeneration of the injured skeletal myofiber involves fusion of intracellular vesicles with 
sarcolemma and fusion of the muscle progenitor cells respectively. In vitro experiments have identified 
involvement of Annexin A1 (Anx A1) in both these fusion processes. To determine if Anx A1 contributes 
to these processes during muscle repair in vivo, we have assessed muscle growth and repair in Anx A1-
deficient mouse (AnxA1−/−). We found that the lack of Anx A1 does not affect the muscle size and 
repair of myofibers following focal sarcolemmal injury and lengthening contraction injury. However, 
the lack of Anx A1 delayed muscle regeneration after notexin-induced injury. This delay in muscle 
regeneration was not caused by a slowdown in proliferation and differentiation of satellite cells. 
Instead, lack of Anx A1 lowered the proportion of differentiating myoblasts that managed to fuse with 
the injured myofibers by days 5 and 7 after notexin injury as compared to the wild type (w.t.) mice. 
Despite this early slowdown in fusion of Anx A1−/− myoblasts, regeneration caught up at later times 
post injury. These results establish in vivo role of Anx A1 in cell fusion required for myofiber regeneration 
and not in intracellular vesicle fusion needed for repair of myofiber sarcolemma.
Healing injured muscle involves relatively fast (minutes) repair of the injured myofiber cell membrane by fusion of 
intracellular membrane with the cell membrane1. A fiber that fails to repair degenerates and is subsequently regen-
erated over multiple days by a process that involves myogenic differentiation of satellite cells, the muscle-specific 
stem cells, into myoblasts. The myoblasts fuse with each other and with existing myofibers regenerating the dam-
aged myofiber. Thus, the processes of myofiber repair and regeneration both require proteins that facilitate mem-
brane fusion. While a number of proteins involved in these membrane fusion processes have been identified2–10, 
the molecular mechanisms underlying fusion processes leading to repair or regeneration of injured mammalian 
myofiber remain to be understood.
Annexin protein family is known to facilitate membrane fusion and has gained wide recognition for their 
involvement in sarcolemmal repair11,12. Several recent studies have also documented dependence of myogenic 
differentiation and in vitro myoblast fusion on annexin proteins, including annexin A1, Anx A16,13,14. Anx A1 has 
been shown to facilitate cell membrane repair in vitro, where it accumulates at the injured cell membrane12,15,18. 
Cytosolic and extracellular Anx A1, an important regulator of innate and adaptive immunity19, regulates prolif-
eration, differentiation and migration of different cells10; and interacts with the sarcolemmal repair protein dys-
ferlin12,16,20,21. Following in vivo muscle injury, Anx A1 expression increases concomitant with the appearance of 
the first new multinucleated myotubes22(Public Expression Profiling Resource at http://pepr.cnmcresearch.org/). 
1Section on Membrane Biology, Program of Physical Biology, Eunice Kennedy Shriver National Institute of Child Health 
and Human Development, National Institutes of Health, Bldg. 10/Rm. 10D05, 10 Center Dr. Bethesda, Maryland 20892-
1855, USA. 2Children’s National Medical Center, Center for Genetic Medicine Research, 111 Michigan Avenue, NW, 
Washington DC 20010-2970, USA. 3Section on Genome Imprinting, Program on Genomics of Differentiation, Eunice 
Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA. 
4Department of Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, 
Washington DC, USA. *These authors contributed equally to this work. Correspondence and requests for materials 
should be addressed to L.V.C. (email: chernoml@mail.nih.gov) or J.KJ. (email: jkjaiswal@cnmc.org)
Received: 27 August 2015
Accepted: 13 November 2015
Published: 15 December 2015
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 5:18246 | DOI: 10.1038/srep18246
Despite the in vitro evidence of a role of Anx A1 in membrane fusion process needed for myofiber repair and 
regeneration, Anx A1-knockout mice (AnxA1− /− ) display no gross abnormalities23. However, the effect of Anx 
A1 deficit on muscle function, repair and regeneration in vivo has not been investigated.
In this study, we focused on the effects of Anx A1 deficiency on the growth and physiology of mammalian skele-
tal muscles. We observed no detectable differences in muscle between Anx A1− /− and the parental (C57Bl6) wild 
type (w.t.) mice. Both sets of adult animals have similar body weight and weight of specific muscles. We observed 
a small reduction in contractile force of the fast twitch (Extensor Digitorum Longus, EDL) muscle, but not of the 
slow twitch (soleus) muscle. Despite the reduced contractile force of the fast twitch muscle, we did not observe 
any deficit in the ability of the fast twitch muscles from the Anx A1− /− mice to undergo repair following focal 
sarcolemmal injury or following lengthening contraction injury. Similar to our observation in vitro that fusion 
between Anx A1− /− myoblasts is slower at earlier times but then catches up6, we find that the lack of Anx A1 
resulted in a significant delay in the muscle regeneration after notexin-induced injury in vivo. This delay in mus-
cle regeneration in Anx A1− /− animals was not associated with deficits in post-injury activation and myogenic 
differentiation of satellite cells, but with a delay in fusion of activated myoblasts with the regenerating myofibers. 
Our results substantiate the hypothesis that Anx A1 is involved in cell-cell fusion during myofiber regeneration 
following acute muscle injury in vivo but not in muscle development or repair of injured myofiber sarcolemma.
Results
Anx A1 deficit does not alter muscle size and histology. Since Anx A1 was shown to be involved in 
myoblast fusion in vitro6,13,14, we assessed the effect of Anx A1 deficit on the muscle using Anx A1− /− and w.t. 
mice. Similar to what was previously reported23, we found that body weight of Anx A1− /− mice was indistinguish-
able from that of w.t. mice, and observed no difference in the weight of the specific muscles including heart, Soleus, 
EDL, Tibialis Anterior (TA) and Gastrocnemius (Fig. 1). Histological examination of H&E stained Gastrocnemius 
muscles from w.t. and Anx A1− /− mice (Fig. 2A,B) identified no significant difference in the myofiber diameter 
(Fig. 2C), extent of skeletal myofiber degeneration (Fig. 2D), and the number of inflammatory foci (Fig. 2E). The 
total number of myofibers or myonuclei per unit area (Fig. 2F,G), and the number of regenerating fibers (identified 
as centrally nucleated fibers – Fig. 2H) showed no difference between w.t. and Anx A1− /− mice. These results 
indicated that not only does lack of AnxA1 has no effect on body growth and growth of the skeletal muscles, it also 
does not cause muscle degeneration or increase regeneration.
Next, to examine if lack of Anx A1 affects muscle function in vivo, we examined the ability of Anx A1− /− 
muscle to generate contractile force. For this we isolated a slow twitch (soleus) and a fast twitch (EDL) muscle 
from w.t. and Anx A1− /− mice and measured the ability of these muscles to generate contractile force following 
Figure 1. Annexin A1 deficiency does not affect body and muscle weight. (A) Body weight of 4–8 months 
old adult animals (n = 7 for w.t. and n = 4 for Anx A1− /− ). (B–F) Freshly isolated muscles for the heart and 
each of the limb muscles were weighed (n ≥ 8 skeletal muscles for each genotype). All data are expressed as 
means ± S.E.M. and all the differences between the w.t. and Anx A1− /− muscles were statistically insignificant 
(p > 0.4).
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electrophysiological stimulus. Lack of Anx A1 did not affect the contractile force generated by the soleus muscle 
(Fig. 3A), while the EDL muscle showed a reduced specific force as compared to the w.t. mice (Fig. 3B).
Anx A1-deficient myofibers repair efficiently from focal and mechanical injury. In view of the 
lowered contractile force of the EDL muscle and the previously reported involvement of Anx A1 in repair of injured 
plasma membrane of cultured cells15,24,25, we hypothesized that the EDL myofibers have reduced ability to repair 
following acute injury. To test this, in the first approach, we injured the myofibers using stretch-induced injury. 
The loss in contractile force following each round of lengthening contraction-induced injury of Anx A1− /− EDL 
muscle was similar to that of the w.t. EDL muscle indicating that lengthening contraction does not damage the 
AnxA1− /− muscle more than the w.t. muscle (Fig. 3C). This similarity in lengthening contraction injury-induced 
decline in EDL muscle contractile force was even more obvious when the contraction-induced change in specific 
force was normalized to the contractile force prior to stretch induced injury (Fig. 3D). As lengthening contractions 
cause diffuse injury to sarcolemma as well as to myofibrils, in the next approach we directly monitored the kinetics 
of sarcolemmal repair in individual myofiber by controlled focal injury of the sarcolemma using a 10ms pulse 
of a focused laser beam as previously described17. Again, we injured myofibers in a fast twitch muscle (Biceps) 
and monitored repair by quantifying the influx of the membrane impermeant fluorescent probe (FM1-43) into 
the myofiber17. We have previously demonstrated the utility of this approach to monitor poor repair ability of 
biceps myofiber from dysferlin-deficient mice17. Here we observed that the sarcolemma of Anx A1− /− biceps 
myofibers repaired from focal injury with the kinetics that was indistinguishable from that of the w.t. myofibers 
injured in the presence of calcium (Fig. 4A,B). Further, the efficient repair kinetics for both Anx A1 − /− and w.t. 
myofibers injured in the presence of calcium was evident when compared to the w.t. myofibers that failed to repair 
due to injury in the absence of extracellular calcium (Fig. 4B). Thus, using two independent acute myofiber injury 
approaches in intact muscles (not isolated myofibers) we found that there was no detectable difference in the repair 
ability of the Anx A1-deficient myofibers. These results were in agreement with the lack of any histopathology in 
the Anx A1-deficient skeletal muscle (Fig. 2).
Figure 2. Lack of annexin A1 does not lead to histopathology of Gastrocnemius muscle. Paraffin embedded 
muscle from 4 independent animals were sectioned and stained with Hematoxylin and Eosin. The entire stained 
sections were imaged using digital slide scanner using 40x objective. (A,B) Representative histological images 
of the muscle from a w.t. and an Anx A1− /− mice. Scale bar 50 μ m. White arrow shows degenerating fiber and 
white arrowheads show central nuclei marking the recently regenerated fiber. (C) Minimal Feret’s diameter of 
myofibers in the muscles from w.t. and Anx A1− /− mice. (D) Number of degenerating fiber in the muscle in 
w.t. and Anx A1− /− mice. (E) Number of inflammatory foci in the muscle in w.t. and Anx A1− /− mice. (F) 
Number of fiber in the muscle, G. Total number of myonuclei, and (H) Number of centrally nucleated fibers in 
the muscle from w.t. and Anx A1− /− mice. All data shown in C-H are expressed as means ± S.E.M. n = 4 mice. 
All the differences between w.t. and Anx A1− /− data are statistically insignificant (p > 0.05).
www.nature.com/scientificreports/
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Anx A1 deficiency slows down muscle regeneration. Since Anx A1 plays an important role in myoblast 
fusion in vitro6 and is up-regulated during myogenic fusion stage of muscle regeneration22, we next examined the 
effects of Anx A1 deficiency on myoblast fusion in vivo. To induce regeneration, we acutely and focally damaged 
the TA muscle by a notexin injection. Notexin selectively damages the myofibers, triggering a focal muscle necrosis 
and regeneration. Macrophages infiltrate the injured site to remove necrotic debris, which is followed by the acti-
vation of myogenic cells required for muscle regeneration26,27. Post injury regeneration involves proliferation of the 
satellite cells underneath the basal lamina. Thus after notexin injection, the muscle was allowed to regenerate while 
the mice were provided bromodeoxyuridine (BrdU) to label the newly synthesized DNA of dividing cells, resulting 
in their nuclei being labeled with BrdU. Proliferation and differentiation of satellite cells is followed by cell fusion 
to generate new myofibers with centrally located nuclei that upon myofiber maturation move to the periphery.
In the muscle sections at days 3, 5 and 7 after the notexin injury we observed both unregenerated necrotic 
regions and regenerating myofibers (Fig. 5). In the muscle sections at 3 days after notexin-induced injury we 
observed large unregenerated regions infiltrated with macrophages that were positive for the pan-macrophage 
marker F4/80 (Supplementary Fig. 1). Anx A1 deficiency did not affect the density of macrophages in the unre-
generated injured region - 3100 ± 400 macrophages/mm2 vs. 3200 ± 200 macrophages/mm2 (n = 3 mice each). 
Poorly defined borders of the myofibers (identified by the basement membrane staining with anti-laminin antibody 
(Fig. 5A)) hindered quantitative analysis of the regenerating myofibers in these day 3 muscle sections. Thus we 
focused our subsequent analysis of muscle regeneration on the sections taken from days 5 and 7 after notexin injury.
In the sections of muscles 5-day post notexin injection, we observed the laminin-enclosed regenerating myofib-
ers that were always larger than 100 μ m2 and had centrally located nuclei labelled with antibodies to BrdU (“new 
myofibers”), while there were still significant unregenerated, disorganized regions between the fibers (Figs 5,6). 
These unregenerated regions in the vicinity of the injury site were greater in AnxA1− /− muscle sections as com-
pared to the muscle sections from the w.t. mice (Fig. 6). These Anx A1− /− muscle sections also had fewer new 
myofibers as compared to the w.t. (Fig. 7A). Note that our analysis would possibly miss regenerating fibers that 
had not yet formed a basement membrane around them. The differences between the sections taken from w.t. and 
Anx A1− /− mice in the areas of unregenerated regions and in the number of new myofibers disappeared by 7 days 
after injury (Figs 6 and 7A). However, even at this time, the average area of the new fibers in Anx A1− /− mice 
remained smaller than that in w.t. mice (Fig. 7B,C).
Myoblasts that fuse into newly regenerated myofibers are generated by proliferation and subsequent myogenic 
differentiation of satellite cells. To assess if Anx A1 deficit affects number of activated satellite cells, we identified 
cells expressing very early myogenic marker Myf528 in the sections of the regenerating muscles at 5 days after injury 
(Supplementary Fig. 2). Muscle sections from two Anx A1 − /− mice showed 117 ± 7 Myf5-positive cells/mm2 
vs. 120 ± 10 cells/mm2 in the muscle sections from 3 w.t. mice. To compare, the number of Myf5 positive cells in 
uninjured regions of the muscle section from 3 w.t. mice was 10 times lower (10 ± 0.7 cells/mm2). Similar numbers 
of Myf5 positive cells in Anx A1− /− and w.t. muscles show that a deficit in injury-triggered satellite cell activation 
is not the basis for delayed regeneration of notexin-injured AxnA1− /− muscles.
Figure 3. Annexin A1 deficit reduces EDL contractile force but not the ability to recover from lengthening 
contraction injury. Specific force generated by freshly isolated (A) Soleus and (B) EDL muscles was measured 
for w.t. (n = 8 muscles) and Anx A1− /− (n = 6 muscles). (C) Loss in muscle force as a result of repeated 10% 
lengthening contractions of muscles from w.t. (n = 8 muscles) and Anx A1− /− (n = 6 muscles) mice. (D) The 
data presented in C are normalized to the initial forces. All data are expressed as means ± S.E.M. The samples 
were compared by two-tailed unpaired t-test analysis and level of statistical significance of differences is shown 
as * for p ≤ 0.05 and rest of the samples were found to be not significant (p > 0.05).
www.nature.com/scientificreports/
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As neither the inflammation nor satellite cell activation appeared to be affected by AnxA1 deficit, we next 
assessed if fusion of satellite cells to form the nascent myofiber was altered in AnxA1− /− muscle. To identify all 
activated but unfused myoblasts located at the surface of myofibers we co-labelled muscle sections with antibodies 
to a myogenic marker desmin (an intermediate filament protein expressed in the differentiating myoblasts and 
myotubes28–31) and antibodies to BrdU (arrowheads in Fig. 8A,B, also Supplementary Fig. 3). Since we found all 
nascent myofibers with a basement membrane to be larger than100 μ m2, we classified all mononucleated desmin 
positive cells < 100 μ m2 as myoblasts. Additionally, since satellite cells differentiate and fuse into myofibers after 
undergoing a round of replication, we also labeled myogenic nuclei from satellite cells by BrdU labeling. This 
labeling strategy would pick all cells with the nuclei of myogenic origin, enabling us to avoid inflammatory cells. 
However it would also miss any rare myogenic cells that did not divide prior to activation and hence did not 
incorporate BrdU.
Next, we tested if any BrdU positive macrophages that have invaded a damaged myofiber would appear pos-
itive for desmin staining. For this, we tested what fraction of desmin- and BrdU-positive cells also label with the 
macrophage marker F4/80 (Supplementary Fig. 1). In the unregenerated regions of the 3 w.t. muscles at the peak 
of inflammatory response (3rd day post-injury), 947 out of 953 desmin-and BrdU-positive cells did not label for 
F4/80. Similarly out of the 1331 desmin-and BrdU-positive cells in 3 AnxA1− /− muscles, 1314 cells showed no 
F4/80 staining. These data show that macrophages do not appear as desmin-and BrdU-positive cells, indicating 
these are myogenic cells.
Desmin is an intermediate filament protein that is a relatively late marker of myogenic differentiation28–31 but it 
has also been suggested to be detected early in differentiation32. Thus to further characterize if the desmin-positive 
myogenic cells located at the surface of myofibers represent only the late, and not the early stage of differentiation, 
we compared desmin staining with the myogenic cell marker Myf5, which is expressed very early in myogenic 
progression and then downregulated28. In muscle sections 5 days after injury, 39 out of 179 (21.8%) mononucleated 
desmin-positive cells from 3 w.t. muscles (64 fields of view in 6 sections) were labeled with Myf5 (Supplementary 
Fig. 2). From 3 AnxA1− /− muscles (50 fields of view in 6 sections) we found 30 out of 140 (21.4%) mononucle-
ated desmin-positive cells to be Myf5 positive. This demonstrated that 1) the desmin positive mononucleated cells 
represent both early and late stage myoblasts, and 2) at the 5th day post-injury, lack of AnxA1 does not alter the 
proportion of myoblasts at early and late stage of myogenesis.
By the time of our analysis of muscle regeneration, some of the newly generated myoblasts have already fused 
into regenerating myofibers yielding BrdU-labeled nuclei in desmin-labeled myofibers (arrows in Fig. 8A,B). To 
include these cells into analysis, we deduced the number of myogenic cells that have already fused by counting the 
BrdU positive myonuclei in the nascent myofibers. This number was then added to the number of differentiated 
but yet unfused myoblasts (identified as mononucleated desmin-positive, BrdU-positive cells located within the 
myofiber basement membrane). The sum of these two numbers represented the total number of fusion-capable 
myogenic cells. The total numbers of fusion-capable cells in muscle sections taken at 5th and 7th days post-injury 
normalized to the number of new fibers in the same fields of view were indistinguishable between Anx A1− /− 
and w.t. mice (Fig. 8C) indicating that Anx A1- deficit does not inhibit generation of fusion-capable myoblasts. 
However, in the muscle sections taken 5 or 7 days after injury, the proportion of unfused myoblasts to that of new 
myofibers was significantly higher for Anx A1− /− mice as compared to the w.t. mice (Fig. 8D). A lowered efficiency 
of myoblast fusion in regenerating muscle of Anx A1− /− was also revealed by a higher percentage of unfused 
Figure 4. Repair of sarcolemmal injury is not affected by Annexin A1 deficiency. (A) Time-lapse images of 
myofibers of freshly isolated w.t. or Anx A1− /− biceps muscle before as well as 25 and 125 seconds after laser 
injury (white arrow indicates site of injury). Entry of dye into the myofiber is shown by the overlay of FM dye 
fluorescence (green) on the bright field (grayscale) image of the myofibers. (B) Quantification of FM1-43 influx, 
following laser injury into fibers isolated from w.t. in presence or absence of calcium (n = 19 fibers in presence 
and n = 10 in absence) and Anx A1− /− in presence of calcium (n = 20 fibers) from 2 mice for each condition. 
The plots show FM dye intensity averaged for all the fibers at indicated times following injury. The value at each 
time point is normalized to the dye intensity for the fiber at the time of injury (F0) and the error bars represent 
SEM. Scale bar 10 μ m. Statistical difference between the kinetics of increase in averaged FM dye intensity were 
compared by two-tailed unpaired t-test and statistical significance of the difference in kinectis is shown as *** 
for p ≤ 0.001 compared to w.t. and ### for p < 0.001 compared to Anx A1− /− .
www.nature.com/scientificreports/
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myoblasts among all fusion-capable myoblasts (Fig. 8E). Increase in the number of unfused myoblasts without an 
effect on myoblast generation in the injured muscle of Anx A1− /− mice indicates that Anx A1 deficiency slows 
down the myofiber regeneration by inhibiting myoblast fusion.
Discussion
Our results indicate that Anx A1 deficiency does not inhibit muscle growth, cause muscle damage or decrease the 
ability of injured myofiber to repair. Instead, lack of Anx A1 affects myoblast fusion causing a slowdown in regen-
eration of injured muscle. Elevated numbers of unfused myoblasts and lowered fusion efficiency of differentiating 
myoblasts observed in Anx A1− /− mice suggests that regeneration of injured Anx A1-deficient mice is inhibited 
at the cell-cell fusion stage of myofiber formation, rather than at preceding stages of activation and myogenic 
differentiation of satellite cells. This identifies an important role of Anx A1 in facilitating myoblast fusion in vivo.
The Annexin protein family has originated a billion years ago and evolved independently in all major eukar-
yotic phyla33. Most vertebrate tissues, including muscles, express overlapping arrays of the 13 different annexin 
members (reviewed in33–35). Despite distinct expression profiles and properties35,36, all annexin proteins share a 
Figure 5. Sections of the injured and regenerating TA muscle taken from w.t. and Anx A1−/− mice at 
different time after notexin injection. Sections taken 3, 5 and 7 days post-injury (A–C, respectively) were 
labeled with antibodies to laminin (blue) and to BrdU (green) and with propidium iodide (red) to mark 
myofiber borders, nuclei of newly divided cells, and all cell nuclei, respectively. Shown are representative fields 
of view in the vicinity of the injection site. Arrows mark some of the regenerating myofibers identified as 
myofibers with centrally located BrdU-labeled nuclei. Scale bar 50 μ m.
www.nature.com/scientificreports/
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large conserved “core” domain (~30 kDa) responsible for calcium and phospholipid binding. A potential redun-
dancy of contributions of the different members of annexin family in physiology hinders identification of the 
specific functions of different annexins6,33,34. Despite varied functions, annexins have been frequently linked with 
coping with stress and injury. For example, Anx A1 helps plants cope with abiotic membrane stress and signa-
ling37,38. In animal cells, we and others have documented a role of annexins in facilitating repair of injured cell 
membrane12,15,18,39–42. In view of this we hypothesized that Anx A1 deficit would compromise the repair ability 
of injured myofibers. Additionally, we hypothesized that similar to poorly repairing dysferlin-deficient muscle, 
Anx A1 deficiency will increase degeneration and regeneration of the myofibers resulting in reduced contractile 
force. We observed reduced contractile force in the fast (EDL) muscle of the Anx A1− /− mice. However, this did 
not correlate with a concomitant increase in muscle histopathology nor did we observe any effect on the ability of 
the Anx A1− /− muscle fibers to undergo repair from focal laser injury or lengthening contraction injury. These 
findings suggest that the presence of Anx A1 is not critical for myofiber repair in vivo. However, we cannot rule 
out the possibility that Anx A1 may contribute to myofiber repair in vivo, however in its absence another protein 
(perhaps a different annexin or annexins25) substitutes for its role in repair.
In addition to the in vitro role of Anx A1 in cell membrane repair, we and others have documented the involve-
ment of Anx A1 in myoblast fusion in vitro6,13,14. Interestingly, while at early stages of myotube formation, fusion 
between Anx A1-deficient myoblasts proceeds much slower than fusion between w.t. myoblasts, Anx A1-deficient 
myoblasts do catch up and eventually myotube formation is similar to the w.t. myoblasts6. This suggests partial 
redundancy between annexin functions, a conclusion that is supported by the ability of recombinant Anx A5 to 
accelerate fusion between Anx A1− /− myoblasts6. Based on these findings, we analyzed the role of Anx A1 in 
Figure 6. Anx A1 deficiency increases area of unregenerated regions in the vicinity of the injury site 
observed 5 days post injury. (A) Images of the sections taken from w.t. and Anx A1− /− mice 5 days after 
notexin injection and labeled as in Fig. 5. Yellow lines show the borders of unregenerated (necrotic) regions 
(marked by *). Scale bar 50 μ m. (B) Unregenerated (necrotic) regions were identified in muscle sections taken 
from w.t. and Anx A1− /− mice 5 or 7 days after notexin injection (n = 4 for w.t. mice at 7 day post-injury and 
n = 5 for all other conditions). We normalized the total unregenerated area in each analyzed field of view to 
the area of the muscle section in this field and present the means for each mouse in a given condition with a 
line within the group of the points to show the mean of the means for all mice in a given condition. Level of 
statistical significance of differences between w.t. and Anx A1-deficient mice is shown as * for p ≤ 0.05 and the 
rest of the samples were not significantly different from each other, p > 0.05.
www.nature.com/scientificreports/
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myoblast fusion in vivo during the initial days of the post-injury muscle regeneration. Published reports on muscle 
regeneration quantify this process by monitoring the following: a) expression of different myogenic differentiation 
markers at different times post-injury43; b) the size of unregenerated (necrotic) areas in the muscle section44, and 
the number of newly formed (regenerated) myofibers45. In addition to employing all of these metrics, to specifically 
assess the extent of cell-cell fusion without being affected by the proliferation and myogenic commitment of the 
satellite cells, we also used a combination of different end points to assess myoblast differentiation and fusion. We 
found that Anx A1 deficiency does not inhibit myogenic commitment but slows down fusion of differentiating 
myoblasts in regenerating muscle. This in vivo finding recapitulates our earlier finding in vitro that differentiating 
primary myoblasts from Anx A1− /− mice express myogenic differentiation markers myogenin and myosin heavy 
chain similarly to w.t. myoblasts6. This suggests that in a living animal Anx A1 is involved in myoblast fusion rather 
than in pre-fusion stages of the myogenic differentiation.
In the present work we report that the lack of Anx A1 slows muscle regeneration in vivo, but it neither blocks 
myofiber repair nor causes any gross inhibition of muscle development. This finding suggests that during early 
development another annexin is required for proper myoblast fusion leading to normal developmental myogenesis. 
Alternatively, in Anx A1 knockout mouse the function of Anx A1 during early development leading to myoblast 
fusion is taken up by another protein (perhaps another annexin(s)). While our results establish the role of Anx A1 
in the process of myogenesis in vivo, the specifics of this mechanism and the role of Anx A1 in cell fusion needed 
for myogenesis remain to be fully understood.
Methods
Animals. Methods involving animals were approved by the institutional animal care and use committee of 
Children’s Research Institute. All the methods were carried out in accordance with the approved guidelines. 
Animals were maintained in a facility accredited by the American Association for Accreditation of Laboratory 
Animal Care. Methods involving animals were approved by the institutional animal research Committee and 
animals were maintained in a facility accredited by the American Association for Accreditation of Laboratory 
Animal Care. For all experimental procedures adult (4–8 month old) male and female mice were used. Wild type 
(w.t.) mice (C57BL/6) were obtained from Jackson Laboratory (Bar Harbor, ME). Anx A1 knockout mice (Anx 
A1− /− )23 were purchased from Charles River Laboratories UK Ltd (UK). These animals carry an insertion/deletion 
mutation that interrupts exon 2 and deletes exons 3 and 4 of Anx A1.
In vitro force contraction. Mice were anesthetized with intraperitoneal injections containing ketamine 
(100 mg/kg) and xylazine (10 mg/kg). From the right hindlimb, the Extensor Digitorum Longus (EDL) muscle was 
dissected and brought into a bath containing Ringer solution (composition in mM: 137 NaCl, 24 NaHCO3, 11 
Figure 7. Anx A1 deficiency lowers mean number and cross section area of myofibers with centrally 
located BrdU-labeled nuclei in the vicinity of the injury site. (A) New fibers were identified and counted 
in muscle sections taken from w.t. and Anx A1− /− mice 5 or 7 days after notexin injection (n = 4 w.t. mice 
at 7 days post injury and n = 5 mice for each of the other conditions). B, C New fibers were identified and 
their cross-section areas measured for 4 Anx A1− /− mice and 4 w.t. mice at 7 days post injury. (C) All fiber 
cross-section areas for Anx A1− /− mice were pooled together (n = 3266, the distribution shown in pink) and 
compared with the data pooled together for all w.t. mice (n = 3646, the distribution shown in green). (A,B) The 
points are the mean numbers of new fibers in 1 μ m2 of section area (A) and the mean cross section areas of new 
fibers for each mouse in given condition and a line within the group of the points shows the mean of the means 
for all mice in a given condition. (A,B) Level of statistical significance of differences between w.t. and Anx A1-
deficient mice is shown as * for p < 0.05, the rest of the samples were not significantly different from each other, 
p > 0.05.
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glucose, 5 KCl, 2 CaCl2, 1 MgSO4, 1 NaH2PO4, and 0.025 turbocurarine chloride) at 25 °C that was bubbled with 
a mixture of 95%O2 and 5%CO2. With 6–0 silk suture, the proximal tendon was tied to a fixed bottom plate and 
the distal tendon was tied to the arm of a force transducer (Aurora Scientific, Ontario, Canada, model 305B). The 
muscle was surrounded by two platinum electrodes to stimulate the muscle. The optimal length of the muscle was 
established using single 0.2 ms square stimulation pulses. At optimal length, with tetani 300 ms in duration and at 
frequencies of 30, 100, 150, 200, 220 and 250 Hz, each separated by 2 min intervals, the maximal force of the EDL 
was measured and normalized for the muscle cross section area. After measuring the length of the muscle with 
calipers, the muscle was removed from the bath and weighed. The cross section was calculated based on muscle 
mass, fiber length and muscle tissue density. Fiber length was determined based on the ratio of fiber length to 
muscle length of 0.4546. The same procedure was repeated for the soleus muscle from the right hindlimb, but the 
stimulation duration was 1000 ms at frequencies of 30, 50, 80 and 100 Hz. The fiber length to muscle length for 
the soleus muscle was 0.71. Before removing the EDL or soleus muscle from the bath, the muscle was subjected 
to a protocol of lengthening contractions. At optimal length, the EDL muscle was stimulated at 250 Hz for 300 ms 
until a plateau of maximal force generation was reached. From this plateau, with the muscle stimulated, the muscle 
was lengthened over 10% of its length with a velocity of 2 fiber lengths per second after which the muscle was 
passively returned to the optimal length. This was repeated 9 times with 1 min intervals between the lengthening 
contractions. The same procedure was repeated for the soleus muscle, but the muscle was stimulated for 1000 ms 
at 100 Hz and the muscle was lengthened over 20% its length. After removal of the soleus muscle, the mice were 
euthanized with an overdose of CO2 followed by cervical dislocation, and different tissues were collected, weighed 
and embedded as needed.
Figure 8. Anx A1 deficiency lowers efficiency of fusion for differentiating muscle cells. (A,B) Muscle 
sections taken at 7th day post-injury from w.t. (A) and Anx A1− /− (B) mice were labeled with desmin (red) 
and BrdU (green) antibodies to mark differentiating muscle cells and nuclei of newly divided cells, respectively. 
Arrowheads mark differentiating but yet unfused myoblasts identified as desmin-and BrdU-positive cells 
located at the surface of myofibers. Arrows mark nuclei of newly generated myoblasts that had already fused 
and were identified as BrdU-labeled nuclei in desmin-labeled myofibers. Scale bar 20 μ m. (C) The total numbers 
of fusion-committed myogenic cells in muscle sections taken at 5th and 7th days post-injury were quantified 
as the sum of the numbers of fused myoblasts (scored as a number of BrdU-labeled nuclei in myofibers) and 
unfused myoblasts (quantified as desmin- and BrdU- positive cells located within the myofiber basement 
membrane) normalized to the number of new fibers. (D) The numbers of unfused myoblasts in muscle sections 
taken 5 or 7 days after injury were normalized to the numbers of new fibers in the same slices. (E) The numbers 
of unfused differentiating myoblasts in muscle sections taken 7 days after injury were normalized to the total 
numbers of differentiating myoblasts in the same slices. (C–E) The points show the means for each mouse in a 
given condition and a line within the group of the points shows the mean of the means for all mice in a given 
condition. Levels of statistical significance of differences between w.t. and Anx A1-deficient mice are shown 
as * for p < 0.05; and ** for p ≤ 0.01. The rest of the samples were not significantly different from each other, 
p > 0.05.
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Ex vivo cell membrane injury. Biceps muscle were surgically isolated from euthanized w.t. or Anx A1− /− 
mice in Tyrode’s solution and laser injury was carried out using the microscope and laser injury settings as 
described47 in the Tyrode’s buffer containing 1.33 mg/ml FM1-43 dye. The kinetics of repair was determined by 
measuring the cellular FM1-43 dye fluorescence. FM1-43-dye intensity (Δ F/F, where F is the original value at time 0) 
was used to quantify the kinetics of cell membrane repair and represented with intervals of 5 frames.
Histopathology Scoring. For histological analysis, paraffin-embedded muscles from adult mice described 
above were sectioned and stained with haematoxylin and eosin (H&E) as far as possible using the TREAT-NMD 
guidelines for the DMD mouse (http://www.treat-nmd.eu/research/preclinical/dmd-sops/). The images were 
acquired on the VS120 virtual slide microscope (Olympus USA) using the VS-ASWFL software and UPlanSApo 
40x/0.95 objective, and each muscle section was assessed for the following criteria: number of myofibers and myo-
nuclei, myofibers with central nuclei, regenerating myofibers, and inflammatory foci. Minimal Feret’s diameter for 
myofiber was measured using Image J (NIH) plugin.
Notexin injection. 3 months old w.t. and Anx A1− /− mice were anesthetized with peritoneal saline injections 
containing ketamine (100 mg/kg) and xylazine (10 mg/kg) as described before . After hair removal of the legs, 
degeneration/regeneration was induced by intramuscular injection of 30 μ g of notexin into the entire left Tibialis 
Anterior (TA) muscle using Hamilton syringe, while the contralateral TA muscle was not injected. Prior to injection, 
syringe was dipped into a blue tattoo dye in order to label the site of injection. Mice were euthanized at the relevant 
number of days after injection, and both TA were collected, embedded in OCT (optimum cutting temperature) 
and snap frozen in liquid nitrogen-cooled isopentane. All mice were fed 40 mg/mL of Bromodeoxyuridine (BrdU) 
in their drinking water starting a day before the notexin injection until euthanasia to label the new formed nuclei.
Image acquisition. Images were acquired using an inverted fluorescence microscope AxioObserver D1 (Zeiss) 
equipped with 20 × 0.8 NA Plan-Apochromat objective (Zeiss), LUDL filter wheels on both epifluorescence illu-
mination port and image acquisition side port, CoolLed pE-2 LED illuminator (380, 490, 550 and 635 nm), and 
Ixon 885 EMCCD camera (Andor). Microscope, filter wheels, illuminator and camera were controlled using 
Micro-Manager 1.4.13. Fluorescence channels were collected sequentially through a penta-band dichroic mirror 
(FF 408/504/581/667/762, Semrock) using appropriate single band excitation (FF01-387/11, FF02-485/20, FF01-
560/25, FF01-650/13 or FF01-740/13, Semrock) and emission (FF01-440/40, FF01-525/30, FF01-607/36, FF02-
684/24 or FF02-809/81, Semrock) filters. Entire area of each fiber section was automatically scanned and imaged 
using PZ-2000 XYZ Series Automated Stage with Piezo Z-Axis Top Plate (Applied Scientific Instrumentation).
Immunofluorescence. The slides were fixed in ice-cold acetone 10 min at − 20 °C, washed with PBS at the 
room temperature (RT) and incubated in 2N HCl 1 h at 37 °C to denature the DNA for BrdU staining. After 3 
washes with Tris-Buffered Saline (TBS buffer), we neutralized HCl with sodium borate 0.15M for 10 min at RT. 
Then slides were incubated in the blocking solution (7.5 mL of PBS; 2 mL of goat serum; 200 mg of BSA; 50 μ L of 
Triton X100 and 10 μ L of tween 20) for 1 h at RT, incubated overnight at 4 °C with primary antibodies (BrdU + 
laminin) and rinsed 3 times with TBS. After 1h incubation at RT with secondary antibodies and 3 TBS washes 
cell nuclei in the slides were stained with propidium iodide (20 min at RT, Sigma, # P4170, stock: 2.5mg/mL in 
PBS), used in 1/1000 in PBS and washed 3 times with TBS. In some experiments laminin antibodies were replaced 
with desmin antibodies and PI labeling was skipped and either F4/80 or Myf5 antibodies were used. In the case of 
Myf5 labeling, we skipped the acid application and replaced BrdU labeling with Sytox Green (Invitrogen) labeling.
All antibodies were applied in PBS with 10% of blocking solution. BrdU was detected with biotinilated primary 
antibody (Life Technology #B35138) in 1/100 dilution followed with Alexa 488 streptavidin (Invitrogen S32354), 
in 1/500 dilution. Laminin was detected with primary antibody (Sigma #L9393), in 1/400 dilution followed with 
the secondary antibody Marina Blue® goat anti-rabbit IgG (Invitrogen #M10992, in 1/500 dilution). Desmin 
was detected with primary antibody (Abcam, #ab15200, in 1:200 dilution) followed with the secondary antibody 
Alexa-Fluor 568 goat anti-rabbit Ig (Invitrogen, # GA11011, in 1/200 dilution). Macrophages and Myf5-expressing 
cells were detected with F4/80 antibody, clone CI:A3-1 (Abcam, ab6640, in 1/50) and anti-Myf5 Antibody, clone 
1E2G4 (EMD Millipore Biosciences, #MABE74, in 1/50 dilution) followed with the secondary Goat anti-rat 
Alexa-Fluo 350 Invitrogen A21093 in 1/300 dilution.
Analysis and statistics. For muscle histology and membrane repair analysis the data are presented as averaged 
values for all of the muscles or myofibers used for that analysis (described in figure legends). These averaged values 
were compared with each other using unpaired Student’s T-test. To assess muscle regeneration, we analyzed muscle 
sections taken from 4 mice and focused on the fields of view in the vicinity of the injury identified as the fields of 
view with ≥ 10 myofibers with centrally located BrdU-labeled nuclei. For each mouse, we examined 35–50 fields 
of view taken from ≥ 3 slices. The results for all fields of view in all slices for each mouse were pooled together to 
find means for each mouse in each condition. These means were then used to analyze the statistical significance of 
differences between different groups of mice (for instance, to compare 4 w.t. mice and 4 Anx A1− /− mice 5 days 
post-injury). In analysis of the area of new fibers (identified as fibers with centrally located BrdU-labeled nuclei) 
we examined > 3000 fibers for each condition. Statistical analyses were carried out using the unpaired Student’s 
t-test or, when the data were not normally distributed or failed the equal variance test, the Mann-Whitney rank 
sum test in Sigmaplot v.11.0 (Systat Software, San Jose, CA).
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